![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 14/725 | (2006.01) |
C07K 14/47 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 35/26 | (2015.01) |
(11) | Number of the document | 3708579 |
(13) | Kind of document | T |
(96) | European patent application number | 20160141.6 |
Date of filing the European patent application | 2015-03-30 | |
(97) | Date of publication of the European application | 2020-09-16 |
(45) | Date of publication and mention of the grant of the patent | 2024-05-01 |
(46) | Date of publication of the claims translation | 2024-07-25 |
(30) | Number | Date | Country code |
PCT/EP2014/000868 | 2014-04-01 | WO | |
PCT/EP2014/072864 | 2014-10-24 | WO |
(72) |
SAHIN, Ugur , DE
TÜRECI, Özlem , DE
OEHM, Petra , DE
OMOKOKO, Tana , DE
HOFF, Holger , DE
VOSS, Ralf-Holger , DE
BREITKREUZ, Andrea , DE
HOBOHM, Kathleen , DE
MROZ, Karolina Anna , DE
|
(73) |
BIONTECH CELL & GENE THERAPIES GMBH ,
An der Goldgrube 12, 55131 Mainz,
DE
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH , Freiligrathstrasse 12, 55131 Mainz, DE Astellas Pharma Inc. , 5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP |
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Klaudinui-6 specifiniai imunoreceptoriai ir T ląstelių epitopai |
CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES |
Payment date | Validity (years) | Amount | |
2025-03-13 | 11 | 289.00 EUR |
2026-03-30 |